Classes & Events News Get

Post GI ASCO Practice Changing Updates Virtual Symposium-4/26/24

April 26, 2024

Urologic Surgical Care

This conference welcomes a distinguished faculty summarizing the latest data presented at GI ASCO 2024.

Internists, family practitioners, surgeons, medical and radiation oncologists and other physicians, nurses, and allied health professionals.


  1. Recognize the continued increasing incidence of HCC worldwide mainly due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
  2. Review recent studies and updates of immunotherapy and systemic therapy in metastatic Esophagogastric Cancer.
  3. Identify the role of single agent vs. combined immunotherapy in metastatic dMMR mCRC and metastatic anal cancer.
  • Date: April 26, 2024
  • Time: 9:00am to 12:00pm
  • Location: Virtual
  • Credits: 3 AMA PRA Category 1 Credits™

Atlantic Health System is accredited by the Medical Society of New Jersey to provide continuing medical education for physicians. Atlantic Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


9:00am - 9:05amWelcome

Angela Alistar, MD, Medical Director, Gastrointestinal Oncology

Phase 1 Medical Director AHS

9:05am - 10:00amHepatobiliary Practice Changes Updates

Ghassan Abou-Alfa, MD, MBA
Attending, Memorial Sloan Kettering Cancer Center

Professor, Weill Cornell College at Cornell University

10:00am - 10:55amEsophagogastric Cancer Updates

David Ilson, MD, PhD
Attending Physician, Memorial Sloan Kettering

Gastrointestinal Oncology 

10:55 - 11:50amColorectal & Anal Cancer -Practice Changes Updates

Cathy Eng, MD, FACP, FASCO
Vanderbilt-Ingram Cancer Center

David H. Johnson Endowed Chair in Surgical and Medical Oncology
Professor of Medicine, Hematology and Oncology
Director for Strategic Relations
Co-Chairman, NCI GI Steering Committee
Co-Director, GI Oncology
Co-Leader, GI Cancer Research Program
Director, Young Adult Cancers Program

11:50 amClosing Remarks

Angela Alistar, MD
Medical Director, Gastrointestinal/ Oncology

Phase 1 Medical Director

  • Professional Events